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Abstract. It has been reported that the main function of tau protein is to stabilize microtubules and promote the movement
of organelles through the axon in neurons. In Alzheimer’s disease, tau protein is the major constituent of the paired helical
filament, and it undergoes post-translational modifications including hyperphosphorylation and truncation. Whether other
functions of tau protein are involved in Alzheimer’s disease is less clear. We used SH-SY5Y human neuroblastoma cells as an
in vitro model to further study the functions of tau protein. We detected phosphorylated tau protein as small dense dots in the
cell nucleus, which strongly colocalize with intranuclear speckle structures that were also labelled with an antibody to SC35,
a protein involved in nuclear RNA splicing. We have shown further that tau protein, phosphorylated at the sites recognized
by pT231, TG-3, and AD2 antibodies, is closely associated with cell division. Different functions may be characteristic of
phosphorylation at specific sites. Our findings suggest that the presence of tau protein is involved in separation of sister
chromatids in anaphase, and that tau protein also participates in maintaining the integrity of the DNA (pT231, prophase) and
chromosomes during cell division (TG-3).
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INTRODUCTION33
Microtubules, which are a major component of34
the cytoskeleton, are dynamic structures that undergo35
continual assembly and disassembly within the cell36
[1, 2], determine cell shape, and function of the37
intracellular transport of organelles and separation38
of chromosomes during cell division [2], and are39
composed of - and -tubulin dimers [3] and40
their assembly and stability involves microtubule-41
associated proteins (MAPs). The best characterized42
of these are MAP1, MAP2, and tau protein [4]. In43
human brain tissue, six tau isoforms (342–441 amino44
acids in length) are expressed and these are gener-45
ated by alternative splicing of exons 2, 3, and 10.46
Exons 2 and 3 encode two N-terminal inserts, whereas47
exon 10 encodes an additional tandem repeat within48
the C-terminal domain that gives rise to 3- and 4-49
repeat isoforms (3 R and 4 R) [5, 6]. Tau protein has50
been extensively studied since it was identified as51
the major component of the neurofibrillary tangles52
(NFTs) isolated from brains of Alzheimer’s disease53
(AD) patients [6]. NFTs are formed by the accumula-54
tion of abnormal tau and, under electron microscopy,55
appear as paired helical filaments [7, 8]. Tau protein56
can be hyperphosphorylated and truncated, postrans-57
lational events that would favor the generation of a58
series of conformational misfoldings. Tau protein is59
an abundant protein having a diverse cellular distri-60
bution and is likely to have multiple functions; this61
protein, found in the plasma membrane, is dephos-62
phorylated at serine/threonine residues, suggesting63
that the phosphorylation state of tau regulates its64
intracellular trafficking. Dephosphorylation of tau65
may increase the association of tau with trafficking66
proteins which target tau to the plasma membrane67
[9]. Other studies have shown the presence of tau68
protein in the nucleus of both neuronal and non-69
neuronal cells [10–12]. Tau protein, expressed in the70
nucleolus of mitotic HeLa cells, is involved in nucle-71
olar organization [13]. It has also been found in the72
nucleolus of undifferentiated human neuroblastoma73
cells SH-SY5Y, and it has been suggested that nuclear74
tau could participate in the synthesis, assembly, and75
transport of ribosomes [14–16]. Whereas the 3 R tau76
isoform is expressed in undifferentiated SH-SY5Y77
cells, both 3 R and 4 R isoforms are expressed follow-78
ing differentiation of these cells [17]. The splicing79
factor SC35, a member of the superfamily of the80
serine/arginine-rich (SR) protein, promotes inclusion81
of the tau exon 10. Nuclear speckles, as granular82
clusters, are nuclear domains enriched in pre-mRNA83
splicing factors, located in the interchromatin regions 84
of nucleoplasm [18]. 85
The aim of this study was to analyze the pattern of 86
expression and cellular localization of phospho-tau 87
protein during cell cycle division and its relationship 88
with SC35 (speckles) in both cultured neuroblastoma 89
cells and AD brain.
90
MATERIALS AND METHODS 91
Brain tissue 92
Brain tissues from six AD patients were examined 93
in this study (ages 47–90 years, mean 67.5 years, with 94
2–6 hour postmortem delay). These were obtained 95
from the National Brain Bank CINVESTAV, Mex- 96
ico. Autopsies were performed on donors from whom 97
written informed consent had been obtained either 98
from the donor or direct next of kin. The diagnosis 99
of AD was obtained by the NIA-NINCDS group cri- 100
teria [19]. Blocks of the hippocampus and adjacent 101
entorhinal cortex were fixed by immersion in a solu- 102
tion of 4% paraformaldehyde in phosphate-buffered 103
saline (PBS), pH 7.4, at 4ºC for 7 days.
104
Cell culture 105
The human neuroblastoma SH-SY5Y cell line 106
(ATCC, Manassas USA), was maintained in DMEM 107
high glucose (Gibco, USA) supplemented with 108
10% heat-inactivated fetal bovine serum (FBS), 109
l-glutamine (2 mM), penicillin (100 U/ml), and strep- 110
tomycin (100g/ml) under an atmosphere of 5% 111
CO2, in a humidified incubator at 37◦C. 112
For immunofluorescence, cells were seeded at 113
2.5x104 cells on 12 mm glass coverslips. Coverslips 114
were maintained in 4-well dishes (Falcon 1.39 cm2), 115
in DMEM high glucose supplemented with 10% 116
FBS, glutamine and antibiotics in a 5% CO2 incu- 117
bator at 37◦C for 48 h. To induce differentiation, 118
70% confluent cultures were treated for seven days 119
with retinoic acid (10M), in DMEM high glucose 120
supplemented with 1% FBS. Treatment with stau- 121
rosporine (Sigma, St. Louis Mo. USA) was at a 122
concentration of 0.02M for 12 h.
123
Isolation of nuclear fraction 124
The procedure described by Guillemin et al. was 125
used to isolate the nuclear fraction from SH-SY5Y 126
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cells [20]. Briefly, monolayer cultures grown in 100-127
mm petri dishes were harvested by trypsination and128
washed once with PBS. From here on, all the steps129
were done at 4◦C and the buffers supplemented with130
protease and phosphatase inhibitor cocktails (Sigma,131
USA). The pellet was resuspended in CLB buffer132
(10 mM HEPES, 10 mM NaCl, 1 mM KH2PO4,133
5 mM NaHCO3, 5 mM EDTA-Na2, 1 mM CaCl2,134
0.5 mM MgCl2) to a ratio of 7-8x106 cells/0.5 ml135
and then incubated for 5 min on ice. The homoge-136
nization was performed by applying 20–30 passages137
through a 22-gauge needle, then isotonicity of this138
crude homogenate was restored by adding 50l of139
2.5 M sucrose (a small aliquot of this extract was140
kept at –20◦C for further analysis) before centrifuga-141
tion at 6300xg in a tabletop centrifuge (Beckman,142
USA). The pellet was resuspended in 1 ml TSE143
buffer (10 mM Tris, 300 mM sucrose, 1 mM EDTA-144
Na2, 0.1% NP-40) and homogenized by 20 passages145
through a 22-gauge needle. The suspension was cen-146
trifuged at 4000xg for 5 min, the supernatant stored147
at –20◦C as source of cytoplasm extract, and the148
pellet washed with TSE buffer until the supernatant149
was completely clear. The pellet was resuspended150
in 100l TSE buffer (nuclei) and stored at –20◦C151
until used. The protein content of the fractions was152
determined using BCA protein assay (Thermo Fisher153
Scientific, USA).154
Immunoblotting 155
Protein samples (40–50g) were separated by 156
10–12% SDS-PAGE, transferred onto PVDF mem- 157
brane (Bio-Rad, USA) and probed using antibodies 158
to ascertain the purity of the different fractions. Anti- 159
human GAPDH antibody was used as a control for 160
the cytoplasmic fraction and anti-human lamin A/C 161
for nuclear fraction. The detection was visualized 162
after applying specific secondary HRP-conjugated 163
antibodies and exposure to ECL chemiluminescent 164
substrate (Perkin Elmer, USA). 165
Antibodies 166
General characteristics of the antibodies used are 167
summarized in Table 1. 168
Immunofluorescence 169
Double immunolabeling in AD brain tissue 170
Free-floating sliding microtome sections (50m) 171
were treated with Pronase (0.5%) for 20 min and 172
formic acid pure for 1 min before the immunola- 173
beling. After, sections were blocked with a 0.2% 174
IgG-free albumin solution (Sigma Aldrich.) in PBS 175
for 20 min at room temperature. Sections were then 176
incubated with primary antibodies cocktail pSer404
Table 1
Antibodies and recognition sites
Antibody Epitope (amino acid residue numbers) Species and Reference, source
isotype
Alz-50 Tau 5–15, 312–322. Structural conformational change Mo IgM [21, 22]
TG-3 Tau phospho-Thr231. Regional conformational change Mo IgM [23]
pT231 Tau phospho-Thr231 Rb IgG Thermo Fisher
pT235 Tau phospho-Ser235 Rb IgG [24], Abcam
AT100 Tau phospho-Ser202, Thr205, Thr212, Ser214. Regional
conformational change
Mo IgG [25], Thermo Fisher
AD2 Tau phospho-Ser396, Ser404 Mo IgG [26]
pSer396 Tau phospho-Ser396 Rb IgG Thermo Fisher
pSer400 Tau phospho-Ser400 Rb IgG [27], Thermo Fisher
pSer404 Tau phospho-Ser404 Rb IgG Thermo Fisher
pSer422 Tau phospho-Ser422 Rb IgG Thermo Fisher
Tubulin Alpha-tubulin Rb IgG [28], Thermo Fisher
Tau-5 Mid-tau 210–241 Mo IgG [29]
Tau-1 Tau dephosphorylated 195,198, 199 and 202 Mo IgG [30]
Tau-7 Tau C-terminus Mo IgG [31]
T46 Tau 404–441 Mo IgG [32]
Tau499 Tau N-terminus 14–26 Mo IgG [33]
SC35 Recognizes a phospho-epitope of non-snRNP (small nuclear
ribonucleoprotein particles)
Mo IgG [34], Sigma Aldrich
GAPDH Glyceraldehyde 3-phosphate dehydrogenase Rb IgG [35], Millipore
Lamin A/C Lamin A/C Rb IgG Abcam
Mo, mouse; Rb, rabbit; IgG, immunoglobulin G; IgM, immunoglobulin M Fluorescent dyes: Rhodamine phalloidin (Sigma-Aldrich),
TO-PRO-3-iodide (Molecular Probes) were used to visualize actin filaments and nuclei, respectively.
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(1:100 dilution) and T46 (1:100) overnight at 4ºC, and177
then with FITC-tagged goat-anti-rabbit IgG CY5-178
tagged goat anti-mouse IgG secondary antibodies179
(Jackson Immunoresearch Lab Inc., West Grove).180
PBS–0.2% Triton X-100 (Sigma Aldrich) solution181
was used in all of the immunolabeling steps. Sam-182
ples were counterstained with the dye Thiazin red183
(TR) to differentiate non-fibrillar from fibrillar states184
of tau aggregates [36].
185
Double and triple tau protein immunolabeling in186
SH-SY5Y cells187
Cells were fixed with 4% paraformaldehyde in PBS188
(pH7.4) for 30 min at room temperature, followed189
by permeabilization in 0.2% triton-X100 for 10 min190
(Sigma Aldrich) in PBS and then blocked with 0.2%191
IgG-free albumin solution (Sigma Aldrich) in PBS192
for 20 min at room temperature, incubated at 4◦C193
overnight with the primary antibodies (see Table 1)194
and revealed using a mixture of secondary antibod-195
ies specific for species and immunoglobulin isotype196
used. Samples were counterstained with 0.0001%197
To-Pro-3 iodide dye (InVitrogen) in PBS. For triple198
labelling, cells were incubated with a primary anti-199
body cocktail consisting of pT231, pS235, pS396,200
or TG-3 with tubulin at 4◦C overnight and counter-201
stained with To-Pro-3 iodide dye.202
For the detection of the intranuclear speckle203
structures, we used a monoclonal antibody raised204
against the splicing factor SC35 (Sigma Aldrich)205
diluted 1:100. Anti-SC35 and pT231 antibodies were206
applied simultaneously (1:200) and counterstained207
with To-Pro-3 iodide dye in differentiated and undif-208
ferentiated SH-SY5Y cells.
209
Confocal microscopy210
Double and triple immunolabeled sections were211
mounted in anti-quenching media Vectashield (Vec-212
tor Labs, Burlingame) and viewed through a confocal213
laser scanning microscope (TCP-SP8, Leica, Heidel-214
berg) using a 20X dry and 100X oil-immersion plan215
Apochromatic objectives (NA 1.4). Ten to fifteen con-216
secutive single sections were obtained at 0.8–1.0m217
intervals and sequentially scanned in all channels218
throughout the z-axis of the sample. The resulting219
stack of images was projected and analyzed onto the220
two-dimensional plane using a pseudocolor display221
green (FITC), red (TRITC), and blue (CY5). Fluo-222
rochromes in double and triple labeled samples were223
excited at 488 nm (for FITC), 540 nm (for TRITC),224
and 650 nm (for CY5). The autofluorescence of lipo- 225
fuscin granules in AD brain tissue was observed in the 226
red channel. The images were analyzed using Leica 227
SP8 software. 228
Immunoelectronmicroscopy 229
Brain blocks from AD hippocampus were fixed 230
by immersion in a mixture of 4% paraformalde- 231
hyde and 0.2% glutaraldehyde in PBS (pH 7.3) 232
at 40◦C for 2.5 h after post-fixation with a 1% 233
osmium tetroxide solution for one additional hour, 234
tissue was embedded in lowicryl resin and poly- 235
merization was performed under ultraviolet light for 236
72 h. Ultrathin sections were put on nickel grids 237
and then processed for gold-immunolabeling as fol- 238
lows: incubation with Alz50 (1:20 dilution in PBS) 239
for 45 min at room temperature; 2) incubation with 240
an anti-mouse gold-conjugated-IgM secondary anti- 241
body (Amersham, UK) (20 nm particle diameter) 242
diluted at 1:100. As a control for antibody specificity 243
some sections were incubated with the non-AD- 244
related primary antibody, CB-Help1, and similarly 245
processed. Immunolabeled ultrathin section were 246
counterstained with uranyl salts and viewed using an 247
electron microscope (JEOL, JEEM 2000EX). 248
RESULTS 249
Expression of tau protein in nucleus 250
Subcellular fractionation of neuroblastoma cells 251
Despite the abundance of axonal tau in neural tis- 252
sue in humans without neurological alterations and 253
in wild-type mice, the protein is difficult to visualize. 254
To demonstrate the presence of nuclear tau, there- 255
fore, we separated the nuclear fraction to show the 256
presence of intact, phosphorylated tau protein in the 257
nucleus. 258
SH-SY5Y neuroblastoma cells were analyzed 259
by immunoblots. These include undifferentiated 260
(Fig. 1A-C, E, F) and differentiated cells (Fig. 1D) 261
separated by SDS-PAGE as total homogenate (lane 262
1), cytosol (lane 2), and nuclear fraction (lane 3). 263
The extent of purification was established by the 264
presence of two bands recognized by lamin A/C at 265
60–75 kDa in the nuclear but not the cytoplasmic frac- 266
tion (Fig. 1E). Conversely, the 38-kDa GAPDH was 267
observed only in the cytoplasmic fraction (Fig. 1F, 268
Lane 3).
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Fig. 1. Immunoblots from undifferentiated SH-SY5Y cells (A-
C, E-F), obtained from total cell homogenate (lane 1), cytosolic
fraction (lane 2), and nuclear fraction (lane 3) with the anti-
bodies indicated. Relative molecular mass for immunoreactive
bands is given on right. Figures show representative figures from
three independent experiments. In the panel below (G, H), dou-
ble immunostaining of cells in culture shows dense spots in the
nucleus (small arrows) labeled with pT231 antibody (green chan-
nel) surrounded by tubulin and actin networks (red channel) and
within the nucleus counterstained with TO-PRO (blue channel). A
cell undergoing division (arrowheads) shows the mitotic spindle
stained strongly for tubulin (G, large arrow) in undifferentiated
cells. For differentiated cells, the immunoreactivity of the pT231
antibody is observed abundantly in the cell nucleus and staining
in the form of a string of beads is observed along the cytoplasmic
extension (H, arrows).
Expression of tau protein in undifferentiated269
SH-SY5Y cells270
Tau-5 (Fig. 1A), an antibody that recognizes an271
epitope in residues 210–241 of tau protein, reacts272
with two dense bands of 45–68 kDa, in the total273
homogenate, and in the cytoplasmic and nuclear274
fractions. Tau-1, an antibody that depends upon 275
the dephosphorylation of tau on residues 195–202 276
(Fig. 1B), reacts with 4 bands of 52–68 kDa in the 277
total homogenate (lane 1). After fractionation, three 278
of these bands were found in the cytoplasmic fraction 279
(lane 2), and a single band of 64 kDa in the nuclear 280
fraction (lane 3). The antibody directed against the 281
phosphorylated tau epitope at amino acid Thr-231 282
(pT231, Fig. 1 C) recognized a dense band in total 283
homogenate (lane 1) and nuclear extract (lane 3), hav- 284
ing an approximate weight of 64 kDa, that was not 285
present in the cytoplasmic fraction (lane2). 286
Expression of phosphorylated tau protein in 287
differentiated human SH-SY5Y cells 288
The pT231 antibody reacted with two bands of 52 289
and 68 kDa in total homogenate that were present in 290
both cytoplasmic and nuclear fractions (Fig. 1D). 291
Expression of the tau protein phosphorylated at 292
Thr-231 is associated with the cell cycle changes 293
pT231 immunoreactivity in undifferentiated cells 294
was seen in thick and dense spots, or speckles, 295
in the nucleus of quiescent cells (Fig. 1 G, small 296
arrows). In addition, a fine granular staining was 297
observed in the cytoplasm. This immunoreactivity 298
increases throughout the cytoplasm as cells enter 299
the division cycle (Fig. 1 G, arrowheads), where the 300
mitotic spindle and microtubules of the cytoskeleton 301
are visualized with tubulin antibody (Fig. 1 G, long 302
arrow). When cells are differentiated with retinoic 303
acid (Fig. 1 H), long cytoplasmic extensions form at 304
the end where the growth cone was detected, and 305
where the expression of pT231 was observed like 306
a string of beads. The cytoskeleton of these cells 307
was revealed with rhodamine-conjugated phalloidin 308
(red channel). Additionally, a granular immunoreac- 309
tive staining pattern was observed in the nucleus of 310
differentiated cells with this antibody. 311
Double immunolabelling with the pT231 and 312
TG-3 antibodies with undifferentiated SH-SY5Y 313
cells 314
The immunoreactivity of the pT231 antibody was 315
associated with intranuclear specks in quiescent cells 316
(Fig. 2A, arrowheads, green channel). As the cells 317
enter the cell cycle, there was an increase of pT231 318
immunoreactivity (Fig. 2A, arrows, red channel). 319
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However, the labeling of the TG-3 antibody was only320
observed in cells undergoing cell division (Fig. 2A,321
arrows, red channel). TG-3 immunoreactivity was322
concentrated in the periphery of the chromosomes323
as revealed by To-PRO (2A-C, blue channel). In324
cells undergoing cytokinesis, pT231 immunoreactiv-325
ity decreases drastically (Fig. 2B, arrows) and dense326
granular staining is observed in the cytoplasm asso-327
ciated with nuclei, in cells in the cytokinesis process328
the TG-3 antibody showed no reactivity (Fig. 2B,329
arrows). Magnification (2A’) of the image 2A, where330
a single optical image is shown, the immunoreactivity331
of the TG-3 antibody (2A’, arrowheads, red channel)332
is more intense in the periphery of the chromosomes.333
However, the immunoreactivity of the pT231 anti- 334
body was observed homogenously throughout the 335
cytoplasm (2A’, green channel) 336
Double immunolabelling with antibodies pT231 337
and AT100 338
The immunoreactivity with the AT100 antibody 339
was characterized as dense granular speckles in qui- 340
escent cells (Fig. 2 C, arrowheads, red channel) and 341
these colocalized with pT231 reactivity (Fig. 2 C, 342
merged image) AT100 immunoreactivity did not 343
increase during cell division (Fig. 2 C, arrows). 344
Fig. 2. Double immunostaining of undifferentiated SH-SY5Y cells with antibodies directed against phosphorylated epitopes in tau protein
(pT231, green channel and TG-3 or AT100, red channel) and contrasted with To-PRO dye (blue channel). A) In quiescent cells the dye is
located in dense granules that are immunoreactive for pT231 (arrowheads). Immunoreactivity for both pT231 and TG-3 increases in cells
undergoing cell cycle (merged image). A’) Magnification of image A, where a single optical image shown on the middle body cell. TG-3
immunoreactivity bordering the chromosomes. B) By the end of cell cycle, immunoreactivity for the pT231 antibody decreases (arrows, green
channel) and, in the periphery, dense spots are observed, while immunoreactivity for TG-3 disappears (red channel). C) Immunoreactivity
for AT100 does not differ in intensity between quiescent cells (arrowheads) and dividing cells (arrows).
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Immunoreactivity pattern of the AD2 antibody in345
undifferentiated SH-SY5Y cells346
The affinity of the AD2 antibody depends on the347
phosphorylation of amino acids serine 396 and ser-348
ine 404. The staining pattern of this antibody was349
characterized by fine granular staining in the nucleus350
of quiescent cells (Fig. 3A, small arrows). However,351
the immunoreactivity of this antibody increased in352
cells entering cell division (Fig. 3A, large arrow).353
At anaphase, AD2 immunoreactivity increased in354
the middle of the cluster of chromosomes migrating355
toward their poles (Fig. 3B).356
Double immunostaining with pT231 and357
anti-tubulin antibodies358
Undifferentiated SHSY-5Y cells were immunos-359
tained with both pT231 (green channel) and tubulin360
(red channel) antibodies (Fig. 4). The immunore-361
activity of pT231, was observed in quiescent362
(post-mitotic) cells as an intranuclear granu-363
lar staining pattern (speckles) (Fig 4A, arrows),364
immunoreactivity to the anti-tubulin antibody clearly365
shows the cytoskeletal fibers of the cytoplasm. pT231366
immunoreactivity increases in the nucleus, where the367
reactivity is characterized by abundant diffuse gran- 368
ular staining in the nucleus (Fig. 4B, short arrows). 369
Condensation of the chromosomes is evident at 370
this stage; the immunoreactivity of the anti-tubulin 371
antibody increases at two dense points at opposite 372
poles to the periphery of the nucleus. The cell is 373
completely round and the immunoreactivity of the 374
pT231 antibody increases considerably in intensity 375
in the cytoplasm and in the microtubular kinetochore 376
(mitotic spindle) is formed (Fig. 4 C). Immunore- 377
activity to pT231 decreases as sister chromatids 378
migrate toward the opposite poles of the cell, at 379
which stage there is scarce granular staining. How- 380
ever, immunoreactivity to pT231 is still observed in 381
the cytosol (Fig. 4D). Finally, when chromosomes are 382
concentrated at each of the poles at the initiation of 383
cytokinesis, diffuse granular pT231 immunoreactiv- 384
ity is scarce. The microtubules become fragmented 385
on preparing for the separation of the sister cells 386
(Fig. 4E). 387
Double immunostaining with SC35 and pT231 388
antibodies 389
The SC35 antibody demonstrates the intranuclear 390
structures called speckles, which are pre-mRNA 391
Fig. 3. Immunolabelling with AD2 (green channel) counterstained with TO-PRO dye. A) Immunoreactivity of the AD2 antibody increases
in cells cycle (large arrow), whereas in quiescent cells there is a fine granular stain in the nucleus (small arrows). B) The affinity for the AD2
antibody is increased (large arrow) between sister chromatids (arrowheads).
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Fig. 4. Double immunostaining with antibodies pT231 (green
channel) and tubulin (red channel), counterstained with the TO-
PRO dye (blue channel). A) pT231 tau is seen in dense spots
in quiescent cells within the nucleus. B) During prophase, con-
densation of the chromosomes is observed, and phospho-tau
immunoreactivity is increased in a diffuse granular staining pattern
(small arrows) with centrioles seen with tubulin antibody (large
arrow). C) During metaphase, the spindle has developed (arrow-
heads) and chromosomes are found in the equator (asterisk). At
this stage, pT231 immunoreactivity fills the entire cellular cyto-
plasm. D) In anaphase, the sister chromatids have separated and
lie towards the poles (arrows), whereas pT231 immunoreactiv-
ity decreases to a diffuse granular staining. E) During telophase,
in cytokinesis and nucleation, pT231 immunoreactivity decreases
drastically (arrowheads).
splicing intranuclear domains found in the interchro-392
matin regions of the cell nucleoplasm. In SH-SY5Y393
cells, the SC35 antibody revealed dense speckles394
in the nucleus of quiescent cells (Fig 5A, green395
channel, arrowhead), which colocalize with pT231396
immunoreactivity (Fig 5A, red channel and merged,397
arrowhead). However, some granules reactive to398
pT231 were not recognized by anti SC35. During399
prophase, the nuclear speckles undergo a redistri-400
bution into dense granules immunoreactive to SC35401
(Fig. 5B). These dense granules colocalize with the402
expression of tau protein, in the nucleus, and a403
diffuse staining was observed in the nucleoplasm404
(Fig. 5B, arrow, green channel). Speckles are com-405
monly observed at the periphery of nuclei. A distinct406
staining pattern for SC35 was observed when chro-407
mosomes were aligned at the equator of the cell.408
At this stage of the cell cycle, SC35 immunore-409
activity decreased and diffuse staining, which does410
not colocalize with tau protein, is increased at this411
stage (Fig. 5 C, arrow). During separation of the sis-412
ter chromatids to the poles, SC35 immunostaining413
decreases to a faint diffuse staining (Fig. 5D, green414
channel) in the daughter cells. At telophase, there 415
were abundant speckles immunoreactive with SC35 416
(Fig. 5E). Associated with the newly formed nuclei, 417
dense dots immunoreactive with SC35 colocalized 418
with pT231 immunoreactivity (Fig. 5E, arrows). At 419
this stage, however, the cytoplasmic reactivity to 420
pT231 decreased. 421
Double immunostaining with SC35 and pT231 422
for SH-SY5Y cells treated with staurosporine 423
SH-SY5Y cells exposed to staurosporine favor the 424
development of cytoplasmic extensions compared to 425
untreated cultures and greater expression of tau pro- 426
tein (red channel) and SC35 (green channel) (Fig. 6A, 427
B). In the cytoplasm, these markers were not colo- 428
calized. The anti-SC35 antibody showed perinuclear 429
fibers in the direction of the prolongations. 430
Nuclear speckles, co-labeled with both SC35 and 431
pT231, were observed in the nucleus. Additionally, 432
diffuse granular staining with pT231, which did not 433
colocalize with SC35, was observed in the terminals 434
of the extensions, where there was a concentration of 435
SC35 protein (Fig. 6B, arrowheads). 436
Expression of nuclear tau protein in brains of AD 437
patients 438
The expression of phosphorylated N-terminal, 439
conformational and truncated tau protein epitopes in 440
NFTs and pre-NFTs was examined in brains from AD 441
patients. Pre-NFTs are the first steps in the aggrega- 442
tion of tau protein in the neuronal soma. The pre-NFT 443
was characterized by diffuse granular cytoplasmic 444
staining revealed by pT231 (Fig. 7A, arrow) and TG- 445
3 (Fig. 7B), and a perinuclear staining with both 446
antibodies was observed (Fig 7A, B). In the double 447
immunostaining with the mAbs pSer404 and Alz50, 448
labeling of an intracellular NFT with pS404 was 449
observed (Fig. 7 C, arrowheads) in addition to stain- 450
ing within the nucleus (Fig. 7 C, D, arrows) and, in 451
the vicinity, dystrophic neurites immunoreactive to 452
Alz50 were observed. Pre-treatment of the tissues 453
with Pronase and formic acid favored labelling by 454
Alz50 in the nucleus (Fig. 7E, arrows) and an NFT 455
reactive with mAb 423 was observed nearby. Immu- 456
noelectron microscopy was used to establish Alz50 457
reactivity associated with nuclear heterochromatin 458
(Fig. 7F, arrows).
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Prophase
Metaphase
Anaphase
Telophase
Fig. 5. Double immunostaining with antibodies raised against the SC35 protein (green channel) and pT231 (red channel). In quiescent cells,
SC35 immunoreactivity colocalized with dense granules positive for pT231. During cell cycle, SC35 immunoreactivity decreases markedly
(B-E arrows, green channel), whereas pT231 immunoreactivity is increased during prophase and anaphase (B-E). During telophase, SC35
immunoreactivity is observed as dense spots, some of which colocalize with pT231 (arrows).
DISCUSSION459
Phosphorylated tau protein in the nucleus460
of SH-SY5Y cells461
Expression of tau protein is found in both neurons462
and non-neuronal cells [11]. In neurons, tau protein is463
located in the axon and dendritic terminals, where it464
serves to stabilize microtubules and assist in the trans-465
port of vesicles and organelles along the axon [37].466
Under pathological conditions, tau protein acquires467
the ability to self-aggregate in paired helical fila-468
ments in AD and other dementias called tauopathies469
[38–43]. Visualization of the tau protein by routine470
immunohistochemistry and immunofluorescence in471
the axon of neurons under normal conditions is com-472
plicated. Similarly, its presence and function within473
the nucleus has been controversial. The observation474
of proteins within the nucleus depends on the method 475
of fixation and permeabilization. Several studies have 476
demonstrated the presence of nuclear tau protein; the 477
variability of results may, in part, be due to the exper- 478
imental system [44]. 479
Our immunohistochemical study of tau protein 480
in undifferentiated neuroblastoma cells (SH-SY5Y) 481
reveals the expression of phosphorylated tau protein 482
in dense speckles within the nucleus, consistent with 483
previous studies [16, 45, 46], and the presence of 484
diffuse granular staining in the cytoplasm. Previous 485
studies in neuroblastoma cells described the presence 486
of non-phosphorylated tau protein recognized by the 487
Tau-1 antibody in the nucleolus. During cell cycle, 488
Tau-1 immunoreactivity exhibits granular staining 489
associated with chromosomes, suggesting that tau 490
protein might have some normal physiological func- 491
tions not necessarily associated with microtubules 492
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Fig. 6. Expression of SC35 and pT231 in undifferentiated staurosporine-treated SH-SY5Y cells. A) SC35 immunoreactivity is strong as
dense spots within the nucleus, which colocalize with pT231 staining. SC35-immunoreactive staining was observed in the cytoplasm,
which is independent of the staining to pT231 in the cytoplasm. B) In the cytoplasmic terminals, an increase in both pT231 tau and SC35
(arrowheads) signals is observed in cultures treated with staurosporine. In contrast, these markers do not colocalize in the cytoplasm (merged
image, arrowhead).
[16, 47, 48]. It has been suggested that the role of tau493
depends on the functional status and development of494
the cell, which hints that tau protein may exert dif-495
ferent functions. In resting MDCK and mesenchymal496
cells in resting, we could have recently observed evi-497
dence the of tau protein in dense specks within the498
nucleus. When the cells they enter the cell cycle, the499
expression of tau is increased similar to that observed500
in SHSY-5Y cells. This raises the following impor-501
tant question is important as to whether: the presence502
of the native nuclear tau protein in some certain cel-503
lular models could can modify its function when it is504
over overexpressed.505
Other markers mainly reveal cytoplasmic tau, sug-506
gesting that tau protein can be found in different507
conformations and that different antibodies may not508
have access to particular epitopes [44]. In this study,509
and it important to emphasize, cells were fixed510
with 4% paraformaldehyde and permeabilized for511
10 min with Triton X-100. Under these conditions,512
in SH-SY5Y cells, we observed expression of phos-513
phorylated tau in nuclear speckles (pT231). These514
observations are in contrast to other studies, in which515
phosphorylated tau protein was not detected in the516
nucleus [16, 45]. We suggest that tau protein can517
be found in both phosphorylated and dephosphory-518
lated forms in the nucleus. The localization may vary 519
depending on the type of cell and in its intranuclear 520
location. However, the roles that phosphorylated and 521
non-phosphorylated tau protein play in the nucleus 522
are not yet understood. A previous study showed 523
the expression of recombinant tau protein in CHO 524
cells during mitosis, the phosphorylated tau protein 525
was observed in the cell nucleus expressed; tau was 526
associated with the mitotic spindle [49]. This is in 527
contrast with our observations for pT231, TG-3, and 528
AD2 in SH-SY5Y cells, immunoreactivity of tau 529
antibodies did not colocalize with the microtubular 530
mitotic spindle. pT231 and TG-3 immunoreactiv- 531
ity is increased throughout the cytoplasm during 532
metaphase. Phosphorylation at Thr-231 was observed 533
throughout the cytoplasm of the cell, encompass- 534
ing the entire mitotic spindle and chromosomes 535
found at the equator of cells possibly organizing 536
and maintaining the integrity of the chromosomes. 537
In an immunohistochemical study of tau expression 538
in the mouse testis, immunoreactivity with antibod- 539
ies directed against phosphorylated tau protein was 540
observed during meiosis, where the AT270 epitope 541
(pT181) was expressed abundantly in the seminif- 542
erous tubules [50]. In past studies, pT231 was not 543
observed, suggesting that tau protein plays a role 544
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Fig. 7. Expression of tau protein in AD brain tissue. A, B) A pre-NFT immunoreactive to pT231, shows cytoplasmic granular staining
(arrows) and an abundant staining in the perinuclear cells (arrowheads). C, D) Double labeling with the antibodies pS404 (green channel)
and Alz50 (blue channel). C) Neurofibrillary tangle is reactive to pAb pS404 (arrowheads), and this antibody also shows immunoreactivity
in the cell nucleus (arrows). At the periphery, dystrophic neurites are positive for both markers. D) pAb pS404 immunoreactivity is shown in
nuclei (arrows), with Alz50 immunoreactivity in the peripheral dystrophic neurite. E) Double immunostaining with mAb 423 (green channel,
arrowhead) and Alz50 (blue channel, arrows), following treatment with Pronase and formic acid, revealed abundant immunoreactivity for
Alz50 in the nucleus of the neuronal cells (blue channel). Autofluorescent lipofuscin granules are also observed in the red channel. F)
Immunoelectron microscopic staining with Alz50 shows the presence of abundant gold particles associated with nuclear heterochromatin
(arrows).
in spermatogenesis. The variation on the expres-545
sion of the epitopes of the tau protein observed546
can be both cell and tissue dependent [51]. The547
TG-3 antibody immunoreactivity evidences a confor-548
mational change dependent on phosphorylation (in549
the amino acids Thr231 and Ser235) [23]. In SH-550
SY5Y cells, TG-3 immunoreactivity was seen only551
in cells that were undergoing cell division. The dis-552
tribution pattern of the TG-3 immunoreactivity was553
diffuse and granular, but stronger immunoreactivity554
was observed in the vicinity of the chromosomes.555
This suggests that the phosphorylation of tau pro-556
tein at Thr231, associated with the conformational557
change, may be facilitated in maintaining the individ-558
uality of the chromosomes at the time of cell division.559
Furthermore, no colocalization was observed with560
tubulin in the mitotic spindle. Stronger immunoreac-561
tivity of TG-3 was observed in the metaphase when562
the chromosomes are condensed at the equator. This563
is consistent with previous studies in which the pres-564
ence of phosphoepitopes, such as TG-3, appear just565
prior to the prophase with maximal expression dur-566
ing metaphase [52]. In AD, the TG-3 epitope has been567
associated with early events of tau protein aggrega- 568
tion (pre-NFT) prior to the formation of paired helical 569
filaments [53, 54]. Antibody AD2 (which requires 570
phosphorylation of amino acids serine at positions 571
396 and serine 404) showed a granular staining in 572
the cytoplasm of quiescent cells. The immunoreac- 573
tivity detected with this antibody increases as does 574
that of the pT231 and TG-3 antibodies in dividing 575
cells. A specific feature of the AD2 antibody is that 576
its immunoreactivity is increased between the mitotic 577
spindles during the separation, at anaphase, of the sis- 578
ter chromatids toward the poles of the cell. Thus, tau 579
might function in the movement and separation of the 580
sister chromatids towards their corresponding centro- 581
somes. Our study has revealed that three tau epitopes 582
are involved in the cell cycle in SH-SY5Y cells: 583
pT231, TG-3, and AD2. The appearance of reactiv- 584
ity to these antibodies at different stages of mitosis, 585
suggest that multiple functions for tau may depend 586
on both the nature of the epitopes exposed and on the 587
stage of the cell cycle at which they are found. The 588
phosphorylation of tau at Thr-231 favors a possible 589
protection and coordination of chromosomes; TG-3 590
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possibly keep the individuality of the chromosomes591
and AD2 is involved in the movement and separation592
of the chromatids toward the poles.593
Further functions for tau may be involved in the594
differentiation of neurons. Tau protein was preferen-595
tially expressed in cytoplasmic extensions although,596
for some cells, tau remained in the nucleus. These597
observations suggest that the translocation of tau598
from the nucleus to the cytoplasm during the tran-599
sition from the undifferentiated to the differentiated600
state may be part of this cellular programming [17].601
Previous studies have described the localization of602
phosphorylated tau protein in LA-N-5 cells, where603
tau protein was observed in both the cytoplasm and604
nucleus. Immunofluorescent staining showed that605
nuclear tau protein is preferentially located in the606
nucleolus; Greenwood JA et al. revealed that 16%607
of the total tau protein is located in the nucleus,608
since tau phosphorylation is observed in the cyto-609
plasm prior to its translocation to the nucleus [45].610
So far, no function has been associated with this611
form of nuclear tau. However, other investigators612
have proposed mechanisms for tau protecting DNA613
in heat-stressed neurons [55]. Our results showed that614
tau phosphorylated at Thr-231 was found in the cyto-615
plasm when cells were exposed to staurosporine, an616
inducer of apoptosis. Previous studies have shown617
that overexpression of phospho-tau inhibits apoptosis618
[46, 56] and, in contrast, its dephosphorylated form619
potentiates apoptosis [57].620
The study of tau protein has been based on its phys-621
iological processing involved in its association and622
stability of microtubules and its pathological modi-623
fications associated with neurodegenerative diseases.624
A better understanding of the location and function of625
tau protein within the nucleus is required. The pres-626
ence of tau protein in the nucleus and in the nucleolus627
suggests that it could be involved in the protection of628
the genome. However, the nature of their transloca-629
tion to the nucleus, conformation and interaction of630
tau protein with DNA and other nuclear proteins sug-631
gests that it could play multiple functions. Our results632
have shown that the expression of tau protein in633
intranuclear dots colocalized with immunoreactivity634
to an antibody raised against the SC35 protein, a pro-635
tein involved in the inclusion of the fourth repeated636
domain of tau. However, SC35 functions inside the637
nucleus and is reported as the only one of the SR638
proteins involved in RNA splicing that remains in639
the nucleus. Previous studies have co-precipitated the640
pre-mRNA with SC35, suggesting that SC35 acts on641
the exonic splicing enhancer for the inclusion of tau642
exon 10. It has been suggested that, in AD, the dereg- 643
ulation of tau exon 10 through SC35 associated with 644
other splice factors favors an uneven expression of 645
the 3 R and 4 R tau isoforms that could initiate or 646
potentiate tau pathology by triggering neurofibrillary 647
degeneration [58]. This would be consistent with our 648
findings in which apoptosis in the SH-SY5Y cells 649
were induced with staurosporine. We observed a mor- 650
phological change in the cells in which cytoplasmic 651
extensions were formed and also observed that SC35 652
was found not only in the nucleus but also in the 653
cytoplasm. In addition, it has been observed that stau- 654
rosporine is involved in neurite outgrowth [59]. The 655
SC35 analysis carried out in dividing neuroblastoma 656
cells. It would be of interest to examine the expres- 657
sion of SC35 and tau protein in differentiated cell and 658
in primary neuronal cultures 659
Our findings suggest that the presence of a spe- 660
cific tau protein conformation, detected by AD2, 661
is involved in the separation of sister chromatid in 662
anaphase, and that other phospho-tau forms main- 663
tain the integrity of DNA in prophase (pT231) and 664
chromosomes during cell division (TG-3). Further 665
investigations may identify other subtle changes in 666
functions for the protein in the nucleus. 667
Nuclear tau in AD 668
In spite of being an abundant tau protein in the 669
brain, it is difficult to visualize tau in the axon and 670
its visualization in the nucleus is even more compli- 671
cated. The presence of tau in the nucleus has been 672
associated with protection mechanisms against DNA 673
damage. It is suggested that the tau protein could be 674
protecting the DNA against the changes that happen 675
in the neuronal soma due to the massive accumula- 676
tion of this protein. In AD brain, phospho-tau protein 677
is expressed in a diffuse granular form in the cyto- 678
plasm in the first stages of aggregation (preNFT). It 679
is important to emphasize that this protein has been 680
commonly observed in the perinuclear zone. The anti- 681
body (pS404) that recognizes tau phosphorylated at 682
amino acid serine 404 was observed to label both 683
NFTs and intranuclear staining. A series of dense 684
specks were observed within the nucleus. Not all anti- 685
bodies showed an affinity for intranuclear tau. This 686
is possibly due to the fixation methods and/or pro- 687
teins to which tau is associated within the nucleus. 688
When the hippocampal sections were treated with 689
Pronase and formic acid, abundant immunoreactivity 690
was observed with the Alz50 antibody within the neu- 691
ronal nucleus. These observations were corroborated 692
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by immuno-gold staining where tau-reactive particles693
were observed abundantly in the heterochromatin and694
in the nucleolus.695
More evidence is needed to determine the possible696
protective effect of tau protein in AD as a conse-697
quence of its extensive accumulation in the neuronal698
soma; or instead, it is possible participation in an699
inflammatory process that favors the accumulation of700
extracellular deposits of amyloid beta peptide. More701
studies are needed to fully understand the activity or702
participation of tau protein in the nucleus.
703
ACKNOWLEDGMENTS704
Authors want to express their gratitude to Dr.705
P. Davies (Albert Einstein College of Medicine,706
Bronx, NY, USA); Lester I. Binder† (North West-707
ern, Chicago, IL, USA) for the generous gift of708
mAbs (TG-3, Alz-50) and (Tau-1, Tau-5, Tau-7),709
respectively; Tec. Amparo Viramontes Pintos for710
the handling of the brain tissue; M. en C. Samadhi711
Moreno-Campuzano for her technical assistance; M712
en C.J. Iva´n Ga´lvan for his support in confocal713
microscopy, and the confocal microscopy unit of714
Laboratorio Nacional de Servicios Experimentales715
(LaNSE), CINVESTAV. We also want to express our716
gratitude to the Mexican families who donated brains717
of loved ones affected with Alzheimer’s disease, and718
made our research possible. This work is dedicated to719
the memory of Professor Dr. Jose´ Rau´l Mena Lo´pez†.720
This work was financially supported by CONACyT721
grants, No. 142293 (to R.M.), 266492 (I.V-F), 239516722
(J.S) and the Mancera-Rese´ndiz family.723
Authors’ disclosures available online (https://724
www.j-alz.com/manuscript-disclosures/19-0155r2).725
REFERENCES726
[1] Tilney LG, Gibbins JR (1969) Microtubules in the formation727
and development of the primary mesenchyme in Arbacia728
punctulata. II. An experimental analysis of their role in729
development and maintenance of cell shape. J Cell Biol 41,730
227-250.731
[2] Stephens RE, Edds KT (1976) Microtubules: structure,732
chemistry, and function. Physiol Rev 56, 709-777.733
[3] Luduena RF, Shooter EM, Wilson L (1977) Structure of the734
tubulin dimer. J Biol Chem 252, 7006-7014.735
[4] Mandelkow E, Mandelkow EM (1995) Microtubules and736
microtubule-associated proteins. Curr Opin Cell Biol 7, 72-737
81.738
[5] Buee L, Bussiere T, Buee-Scherrer V, Delacourte A, Hof739
PR (2000) Tau protein isoforms, phosphorylation and role
in neurodegenerative disorders. Brain Res Brain Res Rev 740
33, 95-130. 741
[6] McLaughlin L, Zemlan FP, Dean GE (1997) Identification of 742
microtubule-associated protein tau isoforms in Alzheimer’s 743
paired helical filaments. Brain Res Bull 43, 501-508. 744
[7] Ruben GC, Novak M, Edwards PC, Iqbal K (2005) 745
Alzheimer paired helical filaments (PHFs) studied by high- 746
resolution TEM: what can vertical Pt-C replication tell us 747
about the organization of the pronase-digested PHF core? 748
Microsc Res Tech 67, 196-209. 749
[8] Ruben GC, Wang JZ, Iqbal K, Grundke-Iqbal I (2005) 750
Paired helical filaments (PHFs) are a family of single 751
filament structures with a common helical turn period: nega- 752
tively stained PHF imaged by TEM and measured before and 753
after sonication, deglycosylation, and dephosphorylation. 754
Microsc Res Tech 67, 175-195. 755
[9] Pooler AM, Hanger DP (2010) Functional implications of 756
the association of tau with the plasma membrane. Biochem 757
Soc Trans 38, 1012-1015. 758
[10] Cross DC, Munoz JP, Hernandez P, Maccioni RB (2000) 759
Nuclear and cytoplasmic tau proteins from human nonneu- 760
ronal cells share common structural and functional features 761
with brain tau. J Cell Biochem 78, 305-317. 762
[11] Lee G, Rook SL (1992) Expression of tau protein in non- 763
neuronal cells: microtubule binding and stabilization. J Cell 764
Sci 102 (Pt 2), 227-237. 765
[12] Maj M, Hoermann G, Rasul S, Base W, Wagner L, Attems 766
J (2016) The microtubule-associated protein tau and its 767
relevance for pancreatic beta cells. J Diabetes Res 2016, 768
1964634. 769
[13] Thurston VC, Zinkowski RP, Binder LI (1996) Tau as a 770
nucleolar protein in human nonneural cells in vitro and in 771
vivo. Chromosoma 105, 20-30. 772
[14] Tanaka T, Zhong J, Iqbal K, Trenkner E, Grundke-Iqbal I 773
(1998) The regulation of phosphorylation of tau in SY5Y 774
neuroblastoma cells: the role of protein phosphatases. FEBS 775
Lett 426, 248-254. 776
[15] Tanaka T, Iqbal K, Trenkner E, Liu DJ, Grundke-Iqbal I 777
(1995) Abnormally phosphorylated tau in SY5Y human 778
neuroblastoma cells. FEBS Lett 360, 5-9. 779
[16] Loomis PA, Howard TH, Castleberry RP, Binder LI (1990) 780
Identification of nuclear tau isoforms in human neuroblas- 781
toma cells. Proc Natl Acad Sci U S A 87, 8422-8426. 782
[17] Uberti D, Rizzini C, Spano PF, Memo M (1997) Character- 783
ization of tau proteins in human neuroblastoma SH-SY5Y 784
cell line. Neurosci Lett 235, 149-153. 785
[18] Spector DL, Lamond AI (2011) Nuclear speckles. Cold 786
Spring Harb Perspect Biol 3, a000646. 787
[19] McKhann G, Drachman D, Folstein M, Katzman R, Price 788
D, Stadlan EM (1984) Clinical diagnosis of Alzheimer’s 789
disease: report of the NINCDS-ADRDA Work Group under 790
the auspices of Department of Health and Human Services 791
Task Force on Alzheimer’s Disease. Neurology 34, 939-944. 792
[20] Guillemin I, Becker M, Ociepka K, Friauf E, Nothwang HG 793
(2005) A subcellular prefractionation protocol for minute 794
amounts of mammalian cell cultures and tissue. Proteomics 795
5, 35-45. 796
[21] Carmel G, Mager EM, Binder LI, Kuret J (1996) The struc- 797
tural basis of monoclonal antibody Alz50’s selectivity for 798
Alzheimer’s disease pathology. J Biol Chem 271, 32789- 799
32795. 800
[22] Jicha GA, Bowser R, Kazam IG, Davies P (1997) Alz-50 and 801
MC-1, a new monoclonal antibody raised to paired helical 802
filaments, recognize conformational epitopes on recombi- 803
nant tau. J Neurosci Res 48, 128-132. 804
Un
co
rre
cte
d A
uth
or
 P
ro
of
14 P. Flores-Rodrı´guez et al. / Phospho-Tau Protein Expression in the Cell Cycle
[23] Jicha GA, Lane E, Vincent I, Otvos L, Jr., Hoffmann R,805
Davies P (1997) A conformation- and phosphorylation-806
dependent antibody recognizing the paired helical filaments807
of Alzheimer’s disease. J Neurochem 69, 2087-2095.808
[24] Bihaqi SW, Zawia NH (2013) Enhanced taupathy and AD-809
like pathology in aged primate brains decades after infantile810
exposure to lead (Pb). Neurotoxicology 39, 95-101.811
[25] Zheng-Fischhofer Q, Biernat J, Mandelkow EM, Illen-812
berger S, Godemann R, Mandelkow E (1998) Sequential813
phosphorylation of Tau by glycogen synthase kinase-3beta814
and protein kinase A at Thr212 and Ser214 generates the815
Alzheimer-specific epitope of antibody AT100 and requires816
a paired-helical-filament-like conformation. Eur J Biochem817
252, 542-552.818
[26] Buee-Scherrer V, Condamines O, Mourton-Gilles C, Jakes819
R, Goedert M, Pau B, Delacourte A (1996) AD2, a820
phosphorylation-dependent monoclonal antibody directed821
against tau proteins found in Alzheimer’s disease. Brain822
Res Mol Brain Res 39, 79-88.823
[27] Song L, Lu SX, Ouyang X, Melchor J, Lee J, Terracina824
G, Wang X, Hyde L, Hess JF, Parker EM, Zhang L (2015)825
Analysis of tau post-translational modifications in rTg4510826
mice, a model of tau pathology. Mol Neurodegener 10, 14.827
[28] Sato S, Sakurai T, Ogasawara J, Shirato K, Ishibashi Y, Oh-828
ishi S, Imaizumi K, Haga S, Hitomi Y, Izawa T, Ohira Y,829
Ohno H, Kizaki T (2014) Direct and indirect suppression830
of interleukin-6 gene expression in murine macrophages by831
nuclear orphan receptor REV-ERBalpha. ScientificWorld-832
Journal 2014, 685854.833
[29] LoPresti P, Szuchet S, Papasozomenos SC, Zinkowski834
RP, Binder LI (1995) Functional implications for the835
microtubule-associated protein tau: localization in oligo-836
dendrocytes. Proc Natl Acad Sci U S A 92, 10369-10373.837
[30] Binder LI, Frankfurter A, Rebhun LI (1985) The distribution838
of tau in the mammalian central nervous system. J Cell Biol839
101, 1371-1378.840
[31] Horowitz PM, LaPointe N, Guillozet-Bongaarts AL, Berry841
RW, Binder LI (2006) N-terminal fragments of tau inhibit842
full-length tau polymerization in vitro. Biochemistry 45,843
12859-12866.844
[32] Merrick SE, Demoise DC, Lee VM (1996) Site-specific845
dephosphorylation of tau protein at Ser202/Thr205 in846
response to microtubule depolymerization in cultured847
human neurons involves protein phosphatase 2A. J Biol848
Chem 271, 5589-5594.849
[33] Wischik CM, Edwards PC, Lai RY, Roth M, Harrington CR850
(1996) Selective inhibition of Alzheimer disease-like tau851
aggregation by phenothiazines. Proc Natl Acad Sci U S A852
93, 11213-11218.853
[34] Fu XD, Maniatis T (1990) Factor required for mammalian854
spliceosome assembly is localized to discrete regions in the855
nucleus. Nature 343, 437-441.856
[35] Ryan TE, Schmidt CA, Green TD, Spangenburg EE, Neufer857
PD, McClung JM (2016) Targeted expression of catalase to858
mitochondria protects against ischemic myopathy in high-859
fat diet-fed mice. Diabetes 65, 2553-2568.860
[36] Mena R, Edwards P, Perez-Olvera O, Wischik CM (1995)861
Monitoring pathological assembly of tau and beta-amyloid862
proteins in Alzheimer’s disease. Acta Neuropathol 89, 50-863
56.864
[37] Johnson GV, Stoothoff WH (2004) Tau phosphorylation in865
neuronal cell function and dysfunction. J Cell Sci 117, 5721-866
5729.867
[38] Abner EL, Kryscio RJ, Schmitt FA, Santacruz KS, Jicha868
GA, Lin Y, Neltner JM, Smith CD, Van Eldik LJ, Nelson869
PT (2011) “End-stage” neurofibrillary tangle pathology in 870
preclinical Alzheimer’s disease: fact or fiction? J Alzheimers 871
Dis 25, 445-453. 872
[39] Defossez A, Beauvillain JC, Delacourte A, Mazzuca M 873
(1988) Alzheimer’s disease: a new evidence for common 874
epitopes between microtubule associated protein Tau and 875
paired helical filaments (PHF): demonstration at the elec- 876
tron microscope level by a double immunogold labelling. 877
Virchows Arch A Pathol Anat Histopathol 413, 141-145. 878
[40] Gertz HJ, Xuereb JH, Huppert FA, Brayne C, Kruger 879
H, McGee MA, Paykel ES, Harrington CR, Mukaetova- 880
Ladinska EB, O’Connor DW, Wischik CM (1996) The 881
relationship between clinical dementia and neuropatholog- 882
ical staging (Braak) in a very elderly community sample. 883
Eur Arch Psychiatry Clin Neurosci 246, 132-136. 884
[41] Kolarova M, Garcia-Sierra F, Bartos A, Ricny J, Ripova D 885
(2012) Structure and pathology of tau protein in Alzheimer 886
disease. Int J Alzheimers Dis 2012, 731526. 887
[42] Spillantini MG, Goedert M, Jakes R, Klug A (1990) Topo- 888
graphical relationship between beta-amyloid and tau protein 889
epitopes in tangle-bearing cells in Alzheimer disease. Proc 890
Natl Acad Sci U S A 87, 3952-3956. 891
[43] Wang Y, Mandelkow E (2016) Tau in physiology and pathol- 892
ogy. Nat Rev Neurosci 17, 5-21. 893
[44] Lu J, Li T, He R, Bartlett PF, Gotz J (2014) Visualizing the 894
microtubule-associated protein tau in the nucleus. Sci China 895
Life Sci 57, 422-431. 896
[45] Greenwood JA, Johnson GV (1995) Localization and in situ 897
phosphorylation state of nuclear tau. Exp Cell Res 220, 332- 898
337. 899
[46] Mookherjee P, Johnson GV (2001) Tau phosphorylation 900
during apoptosis of human SH-SY5Y neuroblastoma cells. 901
Brain Res 921, 31-43. 902
[47] Bukar Maina M, Al-Hilaly YK, Serpell LC (2016) 903
Nuclear tau and its potential role in Alzheimer’s disease. 904
Biomolecules 6, 9. 905
[48] Uberti D, Rizzini C, Galli P, Pizzi M, Grilli M, Lesage A, 906
Spano P, Memo M (1997) Priming of cultured neurons with 907
sabeluzole results in long-lasting inhibition of neurotoxin- 908
induced tau expression and cell death. Synapse 26, 95-103. 909
[49] Preuss U, Doring F, Illenberger S, Mandelkow EM (1995) 910
Cell cycle-dependent phosphorylation and microtubule 911
binding of tau protein stably transfected into Chinese ham- 912
ster ovary cells. Mol Biol Cell 6, 1397-1410. 913
[50] Sigala J, Jumeau F, Caillet-Boudin ML, Sergeant N, Bal- 914
lot C, Rigot JM, Marcelli F, Tardivel M, Buee L, Mitchell 915
V (2014) Immunodetection of Tau microtubule-associated 916
protein in human sperm and testis. Asian J Androl 16, 927- 917
928. 918
[51] Inoue H, Hiradate Y, Shirakata Y, Kanai K, Kosaka K, Gotoh 919
A, Fukuda Y, Nakai Y, Uchida T, Sato E, Tanemura K (2014) 920
Site-specific phosphorylation of Tau protein is associated 921
with deacetylation of microtubules in mouse spermatogenic 922
cells during meiosis. FEBS Lett 588, 2003-2008. 923
[52] Vincent I, Rosado M, Davies P (1996) Mitotic mechanisms 924
in Alzheimer’s disease? J Cell Biol 132, 413-425. 925
[53] Luna-Munoz J, Chavez-Macias L, Garcia-Sierra F, Mena 926
R (2007) Earliest stages of tau conformational changes are 927
related to the appearance of a sequence of specific phospho- 928
dependent tau epitopes in Alzheimer’s disease. J Alzheimers 929
Dis 12, 365-375. 930
[54] Luna-Munoz J, Garcia-Sierra F, Falcon V, Menendez I, 931
Chavez-Macias L, Mena R (2005) Regional conforma- 932
tional change involving phosphorylation of tau protein at 933
the Thr231, precedes the structural change detected by 934
Un
co
rre
cte
d A
uth
or
 P
ro
of
P. Flores-Rodrı´guez et al. / Phospho-Tau Protein Expression in the Cell Cycle 15
Alz-50 antibody in Alzheimer’s disease. J Alzheimers Dis 8,935
29-41.936
[55] Sultan A, Nesslany F, Violet M, Begard S, Loyens A, Tala-937
hari S, Mansuroglu Z, Marzin D, Sergeant N, Humez S,938
Colin M, Bonnefoy E, Buee L, Galas MC (2011) Nuclear939
tau, a key player in neuronal DNA protection. J Biol Chem940
286, 4566-4575.941
[56] Wang HH, Li HL, Liu R, Zhang Y, Liao K, Wang Q, Wang942
JZ, Liu SJ (2010) Tau overexpression inhibits cell apopto-943
sis with the mechanisms involving multiple viability-related944
factors. J Alzheimers Dis 21, 167-179.945
[57] Davis PK, Johnson GV (1999) Energy metabolism and pro- 946
tein phosphorylation during apoptosis: a phosphorylation 947
study of tau and high-molecular-weight tau in differentiated 948
PC12 cells. Biochem J 340 (Pt 1), 51-58. 949
[58] Montejo de Garcini E, Corrochano L, Wischik CM, Diaz 950
Nido J, Correas I, Avila J (1992) Differentiation of neurob- 951
lastoma cells correlates with an altered splicing pattern of 952
tau RNA. FEBS Lett 299, 10-14. 953
[59] Zhaleh H, Azadbakht M, Pour AB (2014) Phosphoinositid 954
signal pathway mediate neurite outgrowth in PC12 cells by 955
staurosporine. Bratisl Lek Listy 115, 203-208. 956
